Methyl morpholine oxide → HCID 85979398, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([C:11]2[C:12]([CH3:18])=[C:13]([CH2:16][OH:17])[S:14][CH:15]=2)(=[O:10])=[O:9])=[CH:4][CH:3]=1.C[N+]1([O-])CCOCC1>C(Cl)Cl.[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([S:8]([C:11]2[C:12]([CH3:18])=[C:13]([CH:16]=[O:17])[S:14][CH:15]=2)(=[O:10])=[O:9])=[CH:6][CH:7]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a suspension of [4-(4-chloro-benzenesulfonyl)-3-methyl-thiophen-2-yl]-methanol (786 mg, 2.60 mmol), 4-methylmorpholine N-oxide (0.46 g, 3.9 mmol), and powdered 4 Å molecular sieves (1.3 g, activated by brief heating in vacuo) in CH2Cl2 (7 mL) was added tetrapropylammonium perruthenate (46 mg, 0.13 mmol). The resulting mixture was stirred for 1 hour, after which it was filtered through a plug of silica (ca. 25 g) eluting with EtOAc. The eluate was evaporated in vacuo and the product was purified by chromatography on silica gel on a FlashMaster system using as eluent heptane/ethyl acetate (linear gradient elution from 1:0 to 1:1). Fractions containing the product were pooled and evaporated in vacuo to yield the title compound (644 mg, 82%). 1H NMR (CDCl3): 2.60 (s, 3 H), 7.53 (d, J=9.0 Hz, 2 H), 7.87 (d, J=8.5 Hz, 2 H), 8.53 (s, 1 H), 10.01 (s, 1 H).
Workup
- filtrationafter which it was filtered through a plug of silica (ca. 25 g)
- washeluting with EtOAc
- customThe eluate was evaporated in vacuo
- customthe product was purified by chromatography on silica gel on a FlashMaster system
- additionFractions containing the product
- customevaporated in vacuo
Sources & evidence
- ORD record
- ord-32ae01b16d5542328b284a31964818eb
- Source dataset
- uspto-grants-2008_05
- Patent number
- US07368472B2
Reaction notes
Loading…